Company profile · Biotech & medical
Welgene Biotech
威健股份有限公司 · 6661
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Welgene Biotech provides biomedical research services, genetic testing services, and sales of related products.[1]
The company focuses on high-throughput genetic testing technologies such as DNA microarrays, next-generation sequencing, and real-time quantitative PCR, serving domestic and Asia-Pacific regional markets.[2]
Its genetic testing services and products are divided into research and clinical applications, including prenatal and reproductive medicine products like non-invasive prenatal testing, prenatal amniotic chips, and preimplantation genetic screening.[2]
Welgene Biotech is based in Taipei City, Taiwan.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$34m | +22.2% | -4.5% |
2024-11 to 2026-10, monthly revenue.
Facts
| Full English name | WELGENE BIOTECH CO.,LTD. |
|---|---|
| Chinese name | 威健股份有限公司 |
| Stock code | 6661 (TPEx) |
| Industry | Biotech & medical |
| Founded | 30 Jan 2003 |
| Listed | 27 Jan 2021 |
| Paid-in capital | NT$233m |
| Chairman | 陳貴弘 |
| President | 林怡杏 |
| Headquarters | 12F., No.3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) |
| Website | http：//www.welgene.com.tw |
| Official business description | 生物醫學研究服務及相關產品銷售，暨基因檢測服務 · 生殖醫學類基因檢測:羊水晶片,胚胎晶片,非侵入性胎兒染色體檢測 · 基因定序或晶片類臨床試驗及科學研究 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 威健股份有限公司 · mops · retrieved 04 Nov 2026
- Annual report 2025 (Chinese), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list